Prognostic Values of Inflammatory Indexes in bevacizumab-treated Patients With Advanced non-small-cell Lung Cancer

References

• BadeBC , DelaCruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin. Chest Med.41(1), 1–24 (2020).
   PubMed Web of Science ®Google Scholar
• HannaN , JohnsonD , TeminSet al.Systemic therapy for stage IV non-small-cell lung cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol.35(30), 3484–3515 (2017).
   PubMed Web of Science ®Google Scholar
• DiakosCI , CharlesKA , McMillanDC , ClarkeSJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol.15(11), e493–e503 (2014).
   PubMed Web of Science ®Google Scholar
• BottaC , BarbieriV , CilibertoDet al.Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients. Cancer Biol. Ther.14(6), 469–475 (2013).
   PubMed Web of Science ®Google Scholar
• GuthrieGJ , CharlesKA , RoxburghCS , HorganPG , McMillanDC , ClarkeSJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit. Rev. Oncol. Hematol.88(1), 218–230 (2013).
   PubMed Web of Science ®Google Scholar
• RossiS , BassoM , StrippoliAet al.Are markers of systemic inflammation good prognostic indicators in colorectal cancer?Clin. Colorectal Cancer16(4), 264–274 (2017).
   PubMed Web of Science ®Google Scholar
• FarolfiA , ScarpiE , GrecoFet al.Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study. Sci. Rep.10(1), 18190 (2020).
   PubMed Web of Science ®Google Scholar
• TempletonAJ , PezaroC , OmlinAet al.Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio. Cancer120(21), 3346–3352 (2014).
   PubMed Web of Science ®Google Scholar
• YangZ , ZhangJ , LuYet al.Aspartate aminotransferase–lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolization. Oncotarget6(40), 43090–43098 (2015).
   PubMedGoogle Scholar
• CampRL , Dolled-FilhartM , RimmDL.X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 10(21), 7252–7259 (2004).
   PubMed Web of Science ®Google Scholar
• GretenFR , GrivennikovSI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity51(1), 27–41 (2019).
   PubMed Web of Science ®Google Scholar
• KumarR , GeunaE , MichalareaVet al.The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. Br. J. Cancer112(7), 1157–1165 (2015).
   PubMed Web of Science ®Google Scholar
• KoehneP , WillamC , StraussE , SchindlerR , EckardtKU , BuhrerC. Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am. J. Physiol. Heart Circ. Physiol.279(2), H817–H824 (2000).
   PubMed Web of Science ®Google Scholar
• RahmaOE , HodiFS. The intersection between tumor angiogenesis and immune suppression. Clin. Cancer Res.25(18), 5449–5457 (2019).
   PubMed Web of Science ®Google Scholar
• RamjiawanRR , GriffioenAW , DudaDG. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy?Angiogenesis20(2), 185–204 (2017).
   PubMed Web of Science ®Google Scholar
• HuijbersEJ , van BeijnumJR , ThijssenVL , SabrkhanyS , Nowak-SliwinskaP , GriffioenAW. Role of the tumor stroma in resistance to anti-angiogenic therapy. Drug Resist. Updat.25, 26–37 (2016).
   PubMed Web of Science ®Google Scholar
• BrandauS , MosesK , LangS. The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: cousins, siblings or twins?Semin. Cancer Biol.23(3), 171–182 (2013).
   PubMed Web of Science ®Google Scholar
• LuT , RamakrishnanR , AltiokSet al.Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J. Clin. Invest.121(10), 4015–4029 (2011).
   PubMed Web of Science ®Google Scholar
• Bottsford-MillerJN , ColemanRL , SoodAK. Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies. J. Clin. Oncol.30(32), 4026–4034 (2012).
   PubMed Web of Science ®Google Scholar
• MentzelT , BrownLF , DvorakHFet al.The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma. Virchows Arch.438(1), 13–22 (2001).
   PubMed Web of Science ®Google Scholar
• NozawaH , ChiuC , HanahanD. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl Acad. Sci. USA103(33), 12493–12498 (2006).
   PubMed Web of Science ®Google Scholar
• FarhoodB , NajafiM , MortezaeeK. CD8+ cytotoxic T lymphocytes in cancer immunotherapy: a review. J. Cell. Physiol.234(6), 8509–8521 (2019).
   PubMed Web of Science ®Google Scholar
• StoneRL , NickAM , McNeishIAet al.Paraneoplastic thrombocytosis in ovarian cancer. N. Engl. J. Med.366(7), 610–618 (2012).
   PubMed Web of Science ®Google Scholar
• BremnesRM , BusundLT , KilvaerTLet al.The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer. J. Thorac. Oncol.11(6), 789–800 (2016).
   PubMed Web of Science ®Google Scholar
• MovahediK , LaouiD , GysemansCet al.Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res.70(14), 5728–5739 (2010).
   PubMed Web of Science ®Google Scholar
• QianBZ , PollardJW. Macrophage diversity enhances tumor progression and metastasis. Cell141(1), 39–51 (2010).
   PubMed Web of Science ®Google Scholar
• MiyagawaY , YanaiA , YanagawaTet al.Baseline neutrophil-to-lymphocyte ratio and C-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer. Oncotarget11(1), 86–98 (2020).
   PubMedGoogle Scholar
• PassardiA , ScarpiE , CavannaLet al.Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer. Oncotarget7(22), 33210–33219 (2016).
   PubMedGoogle Scholar
• TrinhH , DzulSP , HyderJet al.Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT). Clin. Chim. Acta510, 711–716 (2020).
   PubMed Web of Science ®Google Scholar
• SalatiM , FilippiR , VivaldiCet al.The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer. Liver Int.40(3), 704–711 (2020).
   PubMed Web of Science ®Google Scholar
• ZhangJ , ZhangHY , LiJ , ShaoXY , ZhangCX. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Oncotarget8(40), 68837–68846 (2017).
   PubMedGoogle Scholar
• MandaliyaH , JonesM , OldmeadowC , NordmanII. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI). Transl. Lung Cancer Res.8(6), 886–894 (2019).
   PubMed Web of Science ®Google Scholar
• MiyamotoR , InagawaS , SanoN , TadanoS , AdachiS , YamamotoM. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur. J. Surg. Oncol.44(5), 607–612 (2018).
   PubMed Web of Science ®Google Scholar
• LiuZL , ZengTT , ZhouXJet al.Neutrophil–lymphocyte ratio as a prognostic marker for chemotherapy in advanced lung cancer. Int. J. Biol. Markers31(4), e395–e401 (2016).
   PubMed Web of Science ®Google Scholar
• ChanSWS , SmithE , AggarwalRet al.Systemic inflammatory markers of survival in epidermal growth factor-mutated non-small-cell lung cancer: single-institution analysis, systematic review, and meta-analysis. Clin. Lung Cancer22(5), 390–407 (2021).
   PubMed Web of Science ®Google Scholar
• CaoD , XuH , XuX , GuoT , GeW. A reliable and feasible way to predict the benefits of nivolumab in patients with non-small cell lung cancer: a pooled analysis of 14 retrospective studies. Oncoimmunology7(11), e1507262 (2018).
   PubMed Web of Science ®Google Scholar
• LiB , WangS , LiCet al.The kinetic changes of systemic inflammatory factors during bevacizumab treatment and its prognostic role in advanced non-small cell lung cancer patients. J. Cancer10(21), 5082–5089 (2019).
   PubMed Web of Science ®Google Scholar
• ZikosTA , DonnenbergAD , LandreneauRJ , LuketichJD , DonnenbergVS. Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer. Cancer Immunol. Immunother.60(6), 819–827 (2011).
   PubMed Web of Science ®Google Scholar